Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
interferon_beta-1a
|
| gptkbp:administrativeDivision |
once a week
|
| gptkbp:chemicalFormula |
protein
|
| gptkbp:clinicalTrials |
Phase III
disease-modifying therapy recommended_for_MS_treatment |
| gptkbp:community_service |
available
|
| gptkbp:contraindication |
depression
liver enzyme elevation hypersensitivity to interferon beta thyroid dysfunction |
| gptkbp:date |
1996-04-01
|
| gptkbp:dosageForm |
solution
|
| gptkbp:drugInterdiction |
available online
anticoagulants antidepressants other immunosuppressants bioavailability 30% |
| gptkbp:endOfLife |
approximately 8 hours
|
| gptkbp:formulation |
pre-filled syringe
|
| gptkbp:gestationPeriod |
Category C
|
| gptkbp:hasPopulation |
adults
|
| gptkbp:healthcare |
liver function tests
complete blood count thyroid function tests important for adherence |
| https://www.w3.org/2000/01/rdf-schema#label |
Avonex
|
| gptkbp:lastProduced |
gptkb:United_States
|
| gptkbp:launchSite |
upper arm
thigh buttock |
| gptkbp:mandates |
relapsing forms of multiple sclerosis
|
| gptkbp:manufacturer |
gptkb:Biogen
|
| gptkbp:marketedAs |
gptkb:Australia
gptkb:Canada gptkb:European_Union |
| gptkbp:numberOfStudents |
renal
|
| gptkbp:offers |
varies by region
|
| gptkbp:researchInterest |
ongoing
|
| gptkbp:route |
intramuscular injection
|
| gptkbp:sells |
gptkb:Avonex
|
| gptkbp:sideEffect |
fatigue
headache muscle pain injection site reactions flu-like symptoms |
| gptkbp:storage |
refrigerated
|
| gptkbp:triggerType |
immunomodulator
|
| gptkbp:type |
interferon_beta-1a
|
| gptkbp:usedFor |
multiple sclerosis
|